Literature DB >> 2164634

Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells.

A M Honegger1, A Schmidt, A Ullrich, J Schlessinger.   

Abstract

In response to epidermal growth factor (EGF) stimulation, the intrinsic protein tyrosine kinase of EGF receptor is activated, leading to tyrosine phosphorylation of several cellular substrate proteins, including the EGF receptor molecule itself. To test the mechanism of EGF receptor autophosphorylation in living cells, we established transfected cell lines coexpressing a kinase-negative point mutant of EGF receptor (K721A) with an active EGF receptor mutant lacking 63 amino acids from its carboxy terminus. The addition of EGF to these cells caused tyrosine phosphorylation of the kinase-negative mutant by the active receptor molecule, demonstrating EGF receptor cross-phosphorylation in living cells. After internalization the kinase-negative mutant and CD63 have separate trafficking pathways. This limits their association and the extent of cross-phosphorylation of K721A by CD63. The coexpression of the kinase-negative mutant together with active EGF receptors in the same cells suppressed the mitogenic response toward EGF as compared with that in cells that express active receptors alone. The presence of the kinase-negative mutant functions as a negative dominant mutation suppressing the response of active EGF receptors, probably by interfering with EGF-induced signal transduction. It appears, therefore, that crucial events of signal transduction occur before K721A and active EGF receptors are separated by their different endocytic itineraries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164634      PMCID: PMC360914          DOI: 10.1128/mcb.10.8.4035-4044.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.

Authors:  I Lax; F Bellot; A M Honegger; A Schmidt; A Ullrich; D Givol; J Schlessinger
Journal:  Cell Regul       Date:  1990-01

Review 3.  Signal transduction by allosteric receptor oligomerization.

Authors:  J Schlessinger
Journal:  Trends Biochem Sci       Date:  1988-11       Impact factor: 13.807

4.  Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells.

Authors:  J Schlessinger; Y Shechter; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

5.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

6.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

Authors:  R M Kris; I Lax; W Gullick; M D Waterfield; A Ullrich; M Fridkin; J Schlessinger
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

7.  All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor.

Authors:  B L Margolis; I Lax; R Kris; M Dombalagian; A M Honegger; R Howk; D Givol; A Ullrich; J Schlessinger
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

8.  Phosphorylation activates the insulin receptor tyrosine protein kinase.

Authors:  O M Rosen; R Herrera; Y Olowe; L M Petruzzelli; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

10.  Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells.

Authors:  T Hunter; J A Cooper
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

View more
  36 in total

1.  The interaction between the Drosophila secreted protein argos and the epidermal growth factor receptor inhibits dimerization of the receptor and binding of secreted spitz to the receptor.

Authors:  M H Jin; K Sawamoto; M Ito; H Okano
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Maximal aggregation of polynomial dynamical systems.

Authors:  Luca Cardelli; Mirco Tribastone; Max Tschaikowski; Andrea Vandin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-06       Impact factor: 11.205

3.  An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor.

Authors:  J F Timms; M E Noble; M Gregoriou
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

4.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

5.  Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling.

Authors:  Yehenew M Agazie; Michael J Hayman
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 6.  Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Authors:  T Müller; W Kuhn; H Przuntek
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Authors:  Haeshin Lee; Tae Gwan Park
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

8.  A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.

Authors:  M Mohammadi; A M Honegger; D Rotin; R Fischer; F Bellot; W Li; C A Dionne; M Jaye; M Rubinstein; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 9.  Wound-healing studies in transgenic and knockout mice.

Authors:  Richard Grose; Sabine Werner
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

10.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Authors:  X Qian; C M LeVea; J K Freeman; W C Dougall; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.